Find Macimorelin Acetate manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

API Suppliers

API Suppliers

0

USDMF

US DMFs Filed

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

VMF

NDC API

0

Listed Suppliers

Other Suppliers

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

API

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: Macrilen, D-87575 acetate, Macimorelin acetate [usan], 945212-59-9, Aqz1003rmg, Macimorelin acetate (usan)
Molecular Formula
C28H34N6O5
Molecular Weight
534.6  g/mol
InChI Key
WVDSKQXKCDZXLH-OHIDFYLOSA-N
FDA UNII
AQZ1003RMG

Macimorelin Acetate
1 2D Structure

Macimorelin Acetate

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
acetic acid;2-amino-N-[(2R)-1-[[(1R)-1-formamido-2-(1H-indol-3-yl)ethyl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]-2-methylpropanamide
2.1.2 InChI
InChI=1S/C26H30N6O3.C2H4O2/c1-26(2,27)25(35)31-22(11-16-13-28-20-9-5-3-7-18(16)20)24(34)32-23(30-15-33)12-17-14-29-21-10-6-4-8-19(17)21;1-2(3)4/h3-10,13-15,22-23,28-29H,11-12,27H2,1-2H3,(H,30,33)(H,31,35)(H,32,34);1H3,(H,3,4)/t22-,23-;/m1./s1
2.1.3 InChI Key
WVDSKQXKCDZXLH-OHIDFYLOSA-N
2.1.4 Canonical SMILES
CC(=O)O.CC(C)(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC3=CNC4=CC=CC=C43)NC=O)N
2.1.5 Isomeric SMILES
CC(=O)O.CC(C)(C(=O)N[C@H](CC1=CNC2=CC=CC=C21)C(=O)N[C@H](CC3=CNC4=CC=CC=C43)NC=O)N
2.2 Other Identifiers
2.2.1 UNII
AQZ1003RMG
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Aezs-130

2. Aib-dtrp-dgtrp-cho

3. Aib-trp-gtrp-cho

4. Aminoisobutyryl-tryptophyl-tryptophanamine-formyl

5. Ard-07

6. Ep 1572

7. Ep-1572

8. Ep1572

9. Jmv 1843

10. Jmv-1843

11. Jmv1843

12. Macimorelin

13. Macrilen

2.3.2 Depositor-Supplied Synonyms

1. Macrilen

2. D-87575 Acetate

3. Macimorelin Acetate [usan]

4. 945212-59-9

5. Aqz1003rmg

6. Macimorelin Acetate (usan)

7. D-tryptophanamide, 2-methylalanyl-n-((1r)-1-(formylamino)-2-(1h-indol-3-yl)ethyl)-, Acetate (1:1)

8. N2-(2-amino-2-methylpropanoyl-n1-((1r)-1-formamido-2-(1h-indol-3-yl)ethyl)- D-tryptophanamide Acetate

9. Ard 07 Acetate

10. Ep 1572 Acetate

11. Unii-aqz1003rmg

12. Aezs 130

13. Macrilen (tn)

14. Ard-07 Acetate

15. Aib-trp-gtrp-cho Acetate

16. Ep-1572 Acetate

17. Chembl2364617

18. Macimorelin Acetate [mi]

19. Dtxsid40241516

20. Macimorelin Acetate [who-dd]

21. Macimorelin Acetate [orange Book]

22. D10562

23. Q27274071

2.4 Create Date
2013-06-11
3 Chemical and Physical Properties
Molecular Weight 534.6 g/mol
Molecular Formula C28H34N6O5
Hydrogen Bond Donor Count7
Hydrogen Bond Acceptor Count6
Rotatable Bond Count9
Exact Mass534.25906821 g/mol
Monoisotopic Mass534.25906821 g/mol
Topological Polar Surface Area182 Ų
Heavy Atom Count39
Formal Charge0
Complexity792
Isotope Atom Count0
Defined Atom Stereocenter Count2
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count2
4 Drug and Medication Information
4.1 Drug Indication

This medicinal product is for diagnostic use only. GHRYVELIN is indicated for the diagnosis of growth hormone deficiency (GHD) in adults.


5 Pharmacology and Biochemistry
5.1 FDA Pharmacological Classification
5.1.1 Pharmacological Classes
Growth Hormone Secretagogue Receptor Agonists [MoA]; Growth Hormone Secretagogue Receptor Agonist [EPC]
5.2 ATC Code

V04CD06


Patents & EXCLUSIVITIES

Check the patents & exclusivity for this product

US Patents

read-more
read-more

01

arrow
Cosmoprof India
Not Confirmed

NOVO

Denmark
arrow
Cosmoprof India
Not Confirmed

MACIMORELIN ACETATE

US Patent Number : 8192719

Drug Substance Claim :

Drug Product Claim :

Application Number : 205598

Patent Use Code : U-2220

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2027-10-12

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty